| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022756 |
| Receipt No. | R000025386 |
| Official scientific title of the study | Multicenter randamized study for evaluating the effect of dantrolene aganst heart failure and arrhythmia |
| Date of disclosure of the study information | 2016/06/15 |
| Last modified on | 2016/06/15 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Multicenter randamized study for evaluating the effect of dantrolene aganst heart failure and arrhythmia | |
| Title of the study (Brief title) | Dantrolene heart failure study | |
| Region |
|
|
| Condition | ||
| Condition | heart failure | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the effect of dantrolene aganst heart failure and arrhythmia |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | left ventricular ejection fraction, ocurence of arrhythmia |
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -no one is blinded |
| Control | Active |
| Stratification | YES |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | Central registration |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | dantrolene treatment/non-dantrolene treatment | |
| Interventions/Control_2 | dantrolene treatment for 2 years | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)Age: from 20 years old to 85 years old
2)Heart disease with/without arrhythmia 3)Patients receive the treatment according to AHA/ACC heart failure guideline 4)Patients gave acceptance for the enrollment to this study 5)in-patients and out-patients can be included in the present study |
|||
| Key exclusion criteria | 1)severe COPD
2)GM 3)severe liver dydfunction 4)ileus |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Shigeki Kobayashi |
| Organization | Yamaguchi University Graduate School of Medicine |
| Division name | Division of Cardiology |
| Address | 1-1-1 Minamikogushi, Ube, Yamaguchi, 755-8505, Japan |
| TEL | 0836-22-2248 |
| skoba@yamaguchi-u.ac.jp | |
| Public contact | |
| Name of contact person | Shigeki Kobayashi |
| Organization | Yamaguchi University Hospital |
| Division name | Division of Cardiology |
| Address | 1-1-1 Minamikogushi, Ube, Yamaguchi, 755-8505, Japan |
| TEL | 0836-22-2248 |
| Homepage URL | |
| skoba@yamaguchi-u.ac.jp | |
| Sponsor | |
| Institute | Yamaguchi University Graduate School of Medicine |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | The ministry of education in Japan |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025386 |